cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Aura Biosciences Inc
1 watching
Current Price
$10.13
$-0.12
(-1.17%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
296.64M
52-Week High
52-Week High
24.83
52-Week Low
52-Week Low
9.43
Average Volume
Average Volume
0.12M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization296.64M
icon52-Week High24.83
icon52-Week Low9.43
iconAverage Volume0.12M
iconDividend Yield--
iconP/E Ratio--
What does the Aura Biosciences Inc do?
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Aura Biosciences Inc make?
News & Events about Aura Biosciences Inc.
Business Wire
2 months ago
Aura Biosciences, Inc. (Aura) (Nasdaq: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the pricing of an underwritten public offering of 6,700,000 shares of its common stock at a...
Business Wire
7 months ago
Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced multiple presentations of data evaluating its first VDC, belzupacap sarotalocan (AU-011), for the...
Market News Video
7 months ago
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys...
Ticker Report
9 months ago
Aura Biosciences, Inc. (NASDAQ:AURA Get Rating) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 333,000 shares, a growth of 73.3% from the March 15th total of 192,200 shares. Based on an average trading volume of 28,900 ...
Frequently Asked Questions
Frequently Asked Questions
What is Aura Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Aura Biosciences Inc shares?
plus_minus_icon
How can I buy Aura Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Aura Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Aura Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Aura Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Aura Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Aura Biosciences Inc?
plus_minus_icon
What percentage is Aura Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Aura Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$10.13
$-0.12
(-1.17%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00